The Nagpur of the Ministry of Health of the State Public Health has set the target of studying 8,000 samples for genome supervision in February under the Integrated Disease Supervision Program (IDSP) following instructions from the National Disease Center (NCDC) and the Ministry of Health of the Union.
The target of the overall genome sequencing (WGS) almost doubled the number of samples studied so far by Nagpur and Pune Labs, officials said.
Until the date, the genome sequencing was carried out only in two cities in this state.
However, there are no individual targets given to any lab.
Director of Joint Health Services, in a letter dated February 10, was written to Deputy Director of Nagpur and Akola Health Services, all medical colleges and city companies to start sending covid positive samples from February 1 to CSIR-Neer Sequencing for.
Joint directors have also asked all authorities and relevant stakeholders to stop sending samples to the National Virology Institute, Pune.
Until now, medical colleges have sent samples to NIV every two weeks.
Sentinel Labs – Virus Research and Diagnostic Laboratory (VRDL) at Indira Gandhi Government Medical College and Hospital (IGGMCH) in the case of Nagpur – from the area also being asked to send two two weeks to neeri to neeri.
Each district has been asked to schedule their samples weekly references with Nodal Officer from Neer Dr.
Krishna Khairnar.
Virological cells The neeri environment is the first in Vidarbha to regulate the genome sequencer.
The cell led by Dr.
Khairnar has made sequencing all genomes of more than 500 samples from Nagpur City in January.
“Following the manufacture of capacity, neeri lab has been recognized by Insacog (Consortium of the Indian SARS-COV2 Genomium) Genome Laboratory Guide / Ordering Regional Genome and Sentinel Center for the Sarscov2 Northeastern (Vidarbha) in Maharashtra.
Therefore, it was decided to choose NEERI LAB on NIV Pune to process samples from Vidarbha.
New targets have been set according to our lab capacity.
However, samples need to meet certain standards for genome studies.
This is one reason why the number is down before the third wave of Covid, “said an ICMR official.
The value of the cycle threshold (CT) is less than 25 is one of the main parameters to select samples for genome studies.
Less value shows the presence of a larger virus.
Priorities will be given to samples of inpatients, especially those on the support of oxygen and ventilators.
Cases with a history of re-infection and extraordinary clinical presentations must also be referred.
Joint Director has instructed to treat a sample of breakthrough infections in priority.
8K samples in February: MAHA set genome study targets
